| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |